Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8198369rdf:typepubmed:Citationlld:pubmed
pubmed-article:8198369lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:8198369lifeskim:mentionsumls-concept:C0029016lld:lifeskim
pubmed-article:8198369lifeskim:mentionsumls-concept:C0376545lld:lifeskim
pubmed-article:8198369pubmed:dateCreated1994-6-30lld:pubmed
pubmed-article:8198369pubmed:abstractTextOncogenes are activated forms of cellular genes involved in normal cell growth and development. Some oncogenes play a role in human malignancies. In hematologic malignancies, researchers have identified many transcription factors as oncogenes based on one of the following criteria: their association with transforming retroviruses in animals, their translocation into either the immunoglobulin or T-cell receptor loci, or the production of fusion proteins resulting from chromosomal translocations. The molecular characterization of oncogenes in hematologic malignancies has led to the discovery of new methods for diagnosis and detection of minimal residual disease. In the future, researchers probably will develop novel treatment strategies to interfere with the function of these oncogenes.lld:pubmed
pubmed-article:8198369pubmed:languageenglld:pubmed
pubmed-article:8198369pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198369pubmed:citationSubsetIMlld:pubmed
pubmed-article:8198369pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198369pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8198369pubmed:statusMEDLINElld:pubmed
pubmed-article:8198369pubmed:issn0066-4219lld:pubmed
pubmed-article:8198369pubmed:authorpubmed-author:BoxerL MLMlld:pubmed
pubmed-article:8198369pubmed:issnTypePrintlld:pubmed
pubmed-article:8198369pubmed:volume45lld:pubmed
pubmed-article:8198369pubmed:ownerNLMlld:pubmed
pubmed-article:8198369pubmed:authorsCompleteYlld:pubmed
pubmed-article:8198369pubmed:pagination1-11lld:pubmed
pubmed-article:8198369pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:meshHeadingpubmed-meshheading:8198369-...lld:pubmed
pubmed-article:8198369pubmed:year1994lld:pubmed
pubmed-article:8198369pubmed:articleTitleThe role of oncogenes in hematologic malignancies.lld:pubmed
pubmed-article:8198369pubmed:affiliationDepartment of Medicine, Stanford University School of Medicine, California.lld:pubmed
pubmed-article:8198369pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8198369pubmed:publicationTypeReviewlld:pubmed